The KMT2A rearrangement is an early event prior to KMT2A-PTD in AML patients with both molecular aberrations
Authors:
- 16 December 2022
- journal article
- letter
- Published by Springer Nature in Annals of Hematology
- Vol. 102 (2) , 495-497
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELNBlood, 2022
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic NeoplasmsLeukemia, 2022
- A rare case of acute megakaryoblastic leukemia with t(11;17)(q23;q21) and KMT2A::MLLT6 fusionAnnals of Hematology, 2022
- Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/ KMT2AProceedings of the National Academy of Sciences, 2020
- Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemiaCancer Genetics, 2020
- Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevanceBlood, 2016
- The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemiasNature Genetics, 2015
- Partial Tandem Duplications of the MLL Gene Are Detectable in Peripheral Blood and Bone Marrow of Nearly All Healthy DonorsBlood, 1998